Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Sept 2026 for KYNTRA BIO, INC., €162.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
David DeLucia: trading record in brief
All filings by David DeLucia on record concern Kyntra Bio, Inc. We count 7 filings; the first trade dates from 6 March 2025 and the latest from 6 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 9 September 2026, the filings show a share grant worth €162 in Kyntra Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David DeLucia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
22 shares@ US$8.550.0000% mcap19.8% of flowCommon StockSEC:0002040705-26-000007:0
52 shares@ US$6.7136.8% of flowCommon StockSEC:0002040705-26-000005:0
60 shares@ US$6.8443.3% of flowCommon StockSEC:0002040705-26-000003:0
52 shares@ US$8.4224.0% of flowCommon StockSEC:0002040705-25-000002:0
51 shares@ US$7.832522.3% of flowCommon StockSEC:0001415889-25-024014:0
2,325 shares@ US$0.3953.7% of flowCommon StockSEC:0001415889-25-007455:0
6 of 6 declarations
